tiprankstipranks
NATCO Pharma Limited (IN:NATCOPHARM)
:NATCOPHARM
India Market

NATCO Pharma Limited (NATCOPHARM) Financial Statements

Compare
2 Followers

NATCO Pharma Limited Financial Overview

NATCO Pharma Limited's market cap is currently ₹138.21B. The company's EPS TTM is ₹104.131; its P/E ratio is 7.41; and it has a dividend yield of 0.78%. NATCO Pharma Limited is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is ₹10.80. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue₹ 40.02B₹ 27.07B₹ 19.05B₹ 16.90B₹ 18.88B
Gross Profit₹ 31.39B₹ 20.80B₹ 12.23B₹ 10.82B₹ 13.78B
Operating Income₹ 25.96B₹ 8.76B₹ 2.20B₹ 5.01B₹ 4.91B
EBITDA₹ 18.80B₹ 10.40B₹ 3.63B₹ 7.10B₹ 6.90B
Net Income₹ 13.88B₹ 7.15B₹ 1.70B₹ 4.41B₹ 4.61B
Balance Sheet
Cash & Short-Term Investments₹ 13.91B₹ 11.62B₹ 7.60B₹ 8.10B₹ 9.03B
Total Assets₹ 69.06B₹ 56.57B₹ 51.09B₹ 47.92B₹ 45.88B
Total Debt₹ 3.86B₹ 1.67B₹ 4.32B₹ 2.84B₹ 3.29B
Net Debt₹ 3.16B₹ 348.00M₹ 3.21B₹ 2.58B₹ 3.10B
Total Liabilities₹ 10.53B₹ -34.80B₹ 8.46B₹ 6.68B₹ 8.03B
Stockholders' Equity₹ 58.53B₹ 48.74B₹ 42.64B₹ 41.22B₹ 37.73B
Cash Flow
Free Cash Flow₹ 8.53B₹ 6.43B₹ -1.96B₹ 442.00M₹ 587.00M
Operating Cash Flow₹ 12.12B₹ 8.49B₹ 465.00M₹ 2.99B₹ 4.17B
Investing Cash Flow₹ -10.33B₹ -4.77B₹ -53.00M₹ -1.03B₹ -1.67B
Financing Cash Flow₹ -2.47B₹ -3.63B₹ 348.00M₹ -1.86B₹ -2.51B
Currency in INR

NATCO Pharma Limited Earnings and Revenue History

NATCO Pharma Limited Debt to Assets

NATCO Pharma Limited Cash Flow

NATCO Pharma Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis